Clinical Scorecard: Global Analysis of Retinal Detachment Incidence and Clinical Features in Acute Retinal Necrosis Using a Federated Database

At a Glance

Key Highlights

• Overall incidence of retinal detachment (RD) following ARN is 12.49%
• 60.5% of RD cases occur within the first 3 months post-ARN diagnosis
• No significant differences in RD incidence based on age, sex, diabetes status, or immunosuppression
• Aggressive combination therapy does not eliminate the risk of RD
• Close ophthalmic monitoring is crucial during the first 3 months after ARN diagnosis

Guideline-Based Recommendations

Diagnosis

• Identify ARN using ICD-10 codes (H30.13, H30.131, H30.132, H30.133, H30.139)

Management

• Consider systemic corticosteroids, oral valacyclovir, and/or intravitreal foscarnet for severe cases

Monitoring & Follow-up

• Monitor patients closely for RD within the first 3 months post-ARN diagnosis

Risks

• RD occurs frequently despite treatment; should be interpreted as a proxy of disease severity

Patient & Prescribing Data

1,785 patients diagnosed with ARN from a large EHR database

Treatment patterns included oral valacyclovir, intravenous acyclovir, and corticosteroids

Clinical Best Practices

• Utilize a multi-institutional database for comprehensive analysis of ARN outcomes
• Perform propensity score matching to reduce baseline differences in cohorts
• Evaluate treatment exposure as proxies of disease severity rather than independent risk factors

Related Resources & Content

• TriNetX Research Network